Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hans M M Groenewoud (J M M Groenewoud, Hans Groenewoud, Hans Mm Groenewoud)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 8

Top Venues

The Journal of dermatological treatment

Psoriasis (Auckland, N.Z.)

JMIR research protocols

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Selma Atalay, Sophie E Berends, Hans M M Groenewoud, Ron A A Mathot, David M Njoo, Johannes M Mommers, Paul M Ossenkoppele, Marjolein I A Koetsier, Maartje A Berends, Annick de Vries, Peter Cornelis Maria van de Kerkhof, Alfons A den Broeder, Elke M G J de Jong, Juul M P A van den Reek
Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial. The Journal of dermatological treatment 33 (5) (2022)
Tamara W van Hal, Juul M P A van den Reek, Hans M M Groenewoud, Marcel C Pasch, Frank H J van den Hoogen, Mark H Wenink, Elke M G J de Jong
Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER): Protocol for a Longitudinal Observational Study. JMIR research protocols 10 (11) (2021)
Femmie de Vegt, Jessie J J Gommers, Hans M M Groenewoud, Peter Derk Siersema, André L M Verbeek, Yonne Peters, Mireille J M Broeders
Trends and projections in the incidence of oesophageal cancer in the Netherlands: An age-period-cohort analysis from 1989 to 2041. International journal of cancer 150 (3) (2021)
Mirjam J Schaap, Susanne C E Broekhuis, Saskia Spillekom-van Koulil, Hans M M Groenewoud, Elke M G J de Jong, Marieke Martha Benedicta Seyger
Treatment goals and preferences of pediatric psoriasis patients, young adults, and parents. The Journal of dermatological treatment (2021)
Selma Atalay, Juul M P A van den Reek, Hans M M Groenewoud, Peter Cornelis Maria van de Kerkhof, Wietske Kievit, Elke M G J de Jong
Two-year follow-up of a dose reduction strategy trial of biologics adalimumab, etanercept, and ustekinumab in psoriasis patients in daily practice. The Journal of dermatological treatment (2021)
Marloes E van Muijen, Tamara W van Hal, Hans M M Groenewoud, Juul M P A van den Reek, Elke M G J de Jong
The Skin May Clear But the Arthritis Won't Disappear: Focusing on Concomitant and New-Onset Psoriatic Arthritis in a Daily Practice Cohort of Psoriasis Patients on Biologic Therapy. Psoriasis (Auckland, N.Z.) 10 (2020)
Marieke E C van Winden, Elke L M Ter Haar, Hans M M Groenewoud, Peter Cornelis Maria van de Kerkhof, Elke M G J de Jong, Satish F K Lubeek
Quality of life, treatment goals, preferences and satisfaction in older adults with psoriasis: a patient survey comparing age groups. The British journal of dermatology 184 (4) (2020)
Laura E Diepeveen, Coby M Laarakkers, Hilde P E Peters, Antonius E van Herwaarden, Hans M M Groenewoud, Joanna IntHout, Jack F M Wetzels, Rachel P L van Swelm, Dorine W Swinkels
Unraveling Hepcidin Plasma Protein Binding: Evidence from Peritoneal Equilibration Testing. Pharmaceuticals (Basel, Switzerland) 12 (3) (2019)

Hans M M Groenewoud.css-eqlu8i{font-size:small;padding-left:4px;} (J M M Groenewoud, Hans Groenewoud, Hans Mm Groenewoud)

Publication Activity (10 Years)

Top Topics

Top Venues

Hans M M Groenewoud (J M M Groenewoud, Hans Groenewoud, Hans Mm Groenewoud)